BioSpace News Archive

Drug Development

January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

January 17, 2019
·
6 min read
·
Mark Terry
Lonza Announces Initiation of S&P Credit Rating with Investment Grade of BBB+ and Stable Outlook

Lonza announced that Standard & Poor’s (S&P) assigned a BBB+ credit rating with stable outlook to Lonza.

January 17, 2019
·
3 min read
Job Trends

BioSpace Movers and Shakers: Jan. 18

Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more.

January 17, 2019
·
4 min read
·
Alex Keown
Deals

Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock at $62.00 Per Share

Mirati Therapeutics, Inc. (Nasdaq: MRTX) announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a price to the public of $62.00 per share.

January 17, 2019
·
5 min read
Medigene AG: Medigene participates at four upcoming conferences

Medigene AG announced its participation at the following upcoming investor and scientific conferences

January 17, 2019
·
1 min read
Business

Almac Group extends personalised cancer vaccine production facilities

The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities.

January 17, 2019
·
3 min read
Business

Cees de Jong: new Chairman of the joint start-up A-Mansia Biotech

A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors.

January 17, 2019
·
2 min read
Business

Food and Drug Law Institute Announces Two New Board Members

The Food & Drug Law Institute (FDLI) is pleased to announce the addition of two new members to the Board of Directors: Cathy Burgess, Partner, Alston & Bird; and Carla Cartwright, Director, Global Regulatory Policy, Johnson & Johnson.

January 17, 2019
·
1 min read
Drug Development

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors

January 17, 2019
·
3 min read
Business

Dental Biomaterials Market to Grow at a CAGR of 4.4% through 2026

The growing edentulous population is expected to be an important factor driving the growth of the global dental biomaterials market throughout the forecast period as people aged 60 years and above are at a high risk of developing dental disorders

January 17, 2019
·
3 min read